189 related articles for article (PubMed ID: 7680106)
21. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
Ashby J; Paton D
Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
[TBL] [Abstract][Full Text] [Related]
22. Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.
Waters M; Jackson M
Toxicol Appl Pharmacol; 2008 Nov; 233(1):34-44. PubMed ID: 18675838
[TBL] [Abstract][Full Text] [Related]
23. Development and impact of the Gene-Tox-Program, genetic activity profiles, and their computerized data bases.
Waters MD
Environ Mol Mutagen; 1994; 23 Suppl 24():67-72. PubMed ID: 8162911
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
[TBL] [Abstract][Full Text] [Related]
25. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay.
Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M
Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667
[TBL] [Abstract][Full Text] [Related]
26. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
27. Deployment of short-term assays for the detection of carcinogens; genetic and molecular considerations.
Ramel C
Mutat Res; 1986 Nov; 168(3):327-42. PubMed ID: 3540645
[TBL] [Abstract][Full Text] [Related]
28. Carcinogenicity evaluations and ongoing studies: the IARC databases.
Vainio H; Coleman M; Wilbourn J
Environ Health Perspect; 1991 Dec; 96():5-9. PubMed ID: 1820277
[TBL] [Abstract][Full Text] [Related]
29. Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Nesnow S; Argus M; Bergman H; Chu K; Frith C; Helmes T; McGaughy R; Ray V; Slaga TJ; Tennant R
Mutat Res; 1987; 185(1-2):1-195. PubMed ID: 3540654
[TBL] [Abstract][Full Text] [Related]
30. Nongenotoxic carcinogens: an extension of the perspective provided by Perera.
Ashby J; Purchase IF
Environ Health Perspect; 1992 Nov; 98():223-6. PubMed ID: 1486853
[TBL] [Abstract][Full Text] [Related]
31. Chromosome mutation tests for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Valencia R; Abrahamson S; Lee WR; Von Halle ES; Woodruff RC; Würgler FE; Zimmering S
Mutat Res; 1984 Jul; 134(1):61-88. PubMed ID: 6431279
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
33. Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.
Elcombe CR; Odum J; Foster JR; Stone S; Hasmall S; Soames AR; Kimber I; Ashby J
Environ Health Perspect; 2002 Apr; 110(4):363-75. PubMed ID: 11940454
[TBL] [Abstract][Full Text] [Related]
34. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.
Zeiger E
Regul Toxicol Pharmacol; 1998 Oct; 28(2):85-95. PubMed ID: 9927558
[TBL] [Abstract][Full Text] [Related]
35. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
36. International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.
Anderson RD; Berger NA
Mutat Res; 1994 Aug; 309(1):109-42. PubMed ID: 7519727
[TBL] [Abstract][Full Text] [Related]
37. The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Lee WR; Abrahamson S; Valencia R; von Halle ES; Würgler FE; Zimmering S
Mutat Res; 1983 Oct; 123(2):183-279. PubMed ID: 6413857
[TBL] [Abstract][Full Text] [Related]
38. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
Silva Lima B; Van der Laan JW
Regul Toxicol Pharmacol; 2000 Oct; 32(2):135-43. PubMed ID: 11067770
[TBL] [Abstract][Full Text] [Related]
40. Which rules for assembling short-term test batteries to predict carcinogenicity?
Benigni R; Giuliani A
Mol Toxicol; 1987; 1(2-3):143-66. PubMed ID: 3449755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
